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Abstract: This review focuses on the expression and regulation of 3β-hydroxysteroid 
dehydrogenase/Δ
5-Δ
4 isomerase (3β-HSD), with emphasis on the porcine version. 3β-HSD 
is often associated with steroidogenesis, but its function in the metabolism of both steroids 
and xenobiotics is more obscure. Based on currently available literature covering humans, 
rodents and pigs, this review provides an overview of the present knowledge concerning 
the regulatory mechanisms for 3β-HSD at all omic levels. The HSD isoenzymes are 
essential in steroid hormone metabolism, both in the synthesis and degradation of steroids. 
They display tissue-specific expression and factors influencing their activity, which 
therefore indicates their tissue-specific responses. 3β-HSD is involved in the synthesis of a 
number of natural steroid hormones, including progesterone and testosterone, and the 
hepatic degradation of the pheromone androstenone. In general, a number of signaling and 
regulatory pathways have been demonstrated to influence 3β-HSD transcription and 
activity, e.g., JAK-STAT, LH/hCG, ERα, AR, SF-1 and PPARα. The expression and 
enzymic activity of 3β-HSD are also influenced by external factors, such as dietary 
composition. Much of the research conducted on porcine 3β-HSD is motivated by its 
importance for the occurrence of the boar taint phenomenon that results from high 
concentrations of steroids such as androstenone. This topic is also examined in this review. 
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1. Introduction 
The elimination of xenobiotics is usually conducted in two phases: Phase I and Phase II. The 
majority of xenobiotics are Phase I metabolized in the liver by the cytochrome P450 (CYP) enzyme 
family. However, though receiving less attention, other enzymes are also able to perform Phase I 
metabolism. One example of such an enzyme is 3β-hydroxysteroid dehydrogenase (3β-HSD), mostly 
known for its role in steroidogenesis and steroid metabolism. In addition, the porcine version of   
3β-HSD has received some attention because of its importance for hepatic clearance of the steroid 
androstenone in sexually mature male pigs. The accumulation of steroids, especially androstenone, is 
associated with a negative perception of the meat from pigs. 
The enzyme 3β-HSD is a key enzyme in the biosynthesis of all active steroid hormones. Several 
different isoforms have been identified in several species. Some of these isoforms are expressed in the 
liver and kidneys or exclusively in the liver [1]. The expression of 3β-HSD in different organs is 
dependent upon developmental stages [2]. In the liver, 3β-HSD functions in steroid degradation and 
the regulation of steroid hormone levels in plasma, as a steroid reductase, and also in the Phase I 
degradation of the male pheromone androstenone [3]. However, its function is not restricted to the 
inactivation of intrinsic steroid hormones [1]. The activity of 3β-HSD is affected by external factors, 
such as diet and environmental toxins. Isoflavones, such as genistein and daidzein, and their 
metabolites have been demonstrated to affect the enzyme kinetics of 3β-HSD in some species [4].  
There are also reports detailing the direct metabolic activity of 3β-HSD on xenobiotics, such as the 
estrogenic mycotoxin zearalenone [5]. Therefore, the regulation of 3β-HSD expression and activity, 
especially in the liver, is an important aspect of the environmental toxicology of xenobiotics. The body 
of humans and animals are challenged with zearalenone via the ingestion of foods such as cereals and 
corn. This compound at high concentrations causes hyperestrogenic effects, such as abortion and 
infertility. For a review of the acute and long-term toxic effects of zearalenone, see Zinedine et al. [6]. 
A portion of the ingested zearalenone has been demonstrated to be converted into metabolites by  
3β-hydroxysteroid dehydrogenase in the livers of pigs and rats [5,7,8]. 
2. 3β-Hydroxysteroid Dehydrogenase 
The membrane-bound enzyme 3β-hydroxysteroid dehydrogenase was first described by   
Samuels et al. [9] in 1951 and later fully characterised by The et al. [10]. It belongs to the family of 
oxidoreductases, which act on the CH–OH group with NAD
+ or NADP
+ as an acceptor. 3β-HSD is 
located both in the endoplasmic reticulum and mitochondria, where it catalyses 3β-hydroxysteroid 
dehydrogenation and Δ
5- to Δ
4-isomerisation of the Δ
5-steroid precursors. This was first demonstrated 
using plasmid transfection to induce the expression of human 3β-HSD isoenzymes [11]. 
3β-HSD belongs to a large protein family called the short-chain dehydrogenases/reductases, which 
includes many representatives with diverse functions and a wide-spread occurrence among living Int. J. Mol. Sci. 2013, 14  17928 
 
 
organisms [12–14]. This is in contrast to 3α-HSD, which is a member of the aldo-keto reductase 
family, characterized by a TIM barrel fold [15–17], which is involved in oxidative cholesterol 
metabolism and regulated via the LXRα-receptor (a “cholesterol sensor”) [18]. 
3β-HSD is required for the biosynthesis of all classes of steroid hormones, such as glucocorticoids, 
mineralocorticoids, progesterone, androgens and estrogens [13]. Enzymes of the 3β-HSD family also 
catalyze the formation and/or degradation of 5α-androstanes and 5α-pregnanes [2]. Thus, 3β-HSD 
controls critical steroid hormone-related reactions in the adrenal cortex, gonads, placenta, liver, and 
other peripheral target tissues [19,20].  
It is hypothesized that for every sex hormone, a pair of HSDs exists, which will either convert a 
potent hormone into its cognate inactive metabolite or vice-versa. HSDs often catalyse stereoselective 
reactions at specific positions of the steroid so that for each sex hormone there is an isoform that either 
will inactivate a hormone or produce an active ligand. This is achieved either by the reduction of a 
steroid ketone to a steroid alcohol (reductase activity) or by the oxidation of a steroid alcohol to a 
steroid ketone (oxidase activity) [21]. 
3. Subcellular Localization 
3β-HSD has a dual subcellular localization in that it is found both in the endoplasmic reticulum 
(ER) and in the mitochondria [22,23]. Within these compartments, histochemical techniques have 
localized 3β-HSD activity to the smooth ER and mitochondrial cristae [24–26]. 3β-HSD’s subcellular 
localization pattern is unique in that it displays various degrees of ER and mitochondrial distribution. 
The relevance of the dual localization is unclear, yet it can be hypothesized that smooth ER-localized 
3β-HSD would have greater access to cytosolic steroid precursors.  
4. Transcriptional Regulation of 3β-HSD 
Most studies of 3β-HSD transcriptional regulation have been conducted on human HSD genes [13]. 
In humans, there are two 3β-HSD isozymes encoded by the HSD3B1 and HSD3B2 genes. In mice, six 
3β-HSD isozymes have been found [27], and in rats, two isoforms have been found [28]. At present, 
only one isoform of 3β-HSD has been described in pigs [29]. 
The gene regulation of 3β-HSD is complex and involves several different factors. During 
development, testicular 3β-HSD expression appears to be separated from luteinizing hormone (LH) 
regulation [30]. In early studies it was determined that cyclic adenosine monophosphate (cAMP) and 
protein kinase-C play a role in the regulation mechanism of 3β-HSD in human choriocarcinoma   
cells [31], potentially linking the mechanism to a number of endocrine and paracrine regulatory 
mechanisms. In adult rat testes, primary control of 3β-HSD expression occurs through the action of the 
LH receptor and the induction of the cAMP second messenger system. LH, forskolin, cAMP, and 
cholera toxin all induce 3β-HSD mRNA in adult rat Leydig cells [32,33]. 
The activation of the protein kinase-C pathway induces the generation of cAMP but also causes a 
near-complete inhibition of the stimulatory effects of human chorion gonadotropin (hCG), LH, 
forskolin, cholera toxin, and cAMP analogues on 3β-HSD mRNA levels in porcine granulosa cells in 
culture [34]. The expression of 3β-HSD in the adrenals has long been known to be influenced by 
adrenocorticotropic hormone and angiotensin II [35]. Int. J. Mol. Sci. 2013, 14  17929 
 
 
On the receptor level a number of mechanisms have been suggested: 
  It has been demonstrated that the nuclear orphan receptor steroidogenic factor 1 (SF-1) controls 
the expression of human 3β-HSD type II [36]. Moreover, it has been observed that the overexpression 
of the SF-1 repressor DAX-1 decreases the expression of 3β-HSD [37]. 
  Another nuclear receptor known to influence 3β-HSD expression is fetoprotein transcription 
factor, also known as liver receptor homologue-1 (LRH-1, NR5A2) [38], which is found in the ovaries, 
testes and adipose tissue. Using a gene-reporter assay, a study demonstrated that co-transfection of 
LRH-1 with a reporter containing the promoter region of the 3β-HSD gene resulted in greater reporter 
activity [39].  
  GATA4 and 6 have been demonstrated to be potential activators of the human 3β-HSD  
promoter [40]. Moreover, it has been demonstrated that co-transfection of GATA with SF-1 and   
LRH-1 induce greater promoter activation than SF-1 and LRH-1 alone [41].  
  In Leydig cells, 3β-HSD transcription has been demonstrated to be regulated via the   
LH/hCG-receptor and the promoter androgen response element [42] and regulated in the liver via the 
receptors estrogen receptor α (ERα), androgen receptor (AR), and cyclin D1 expression [43]. Steroids 
have been demonstrated to be correlated with the expression of 3β-HSD in pig follicles [44], and in 
rainbow trout ovaries, 3β-HSD I is down-regulated by estradiol-17β in vivo [45]. 3β-HSD expression 
has also been demonstrated to be induced by peroxisome proliferator-activated receptor α (PPARα) 
activation in human liver cell lines [46]. 
  It has been demonstrated using knockout mice that the liver X receptor (LXR) represses   
3β-HSD expression in very much the same manner that the constitutive androstane receptor is 
represses the expression of some of the CYPs. Therefore, the binding of LXR agonists can lead to 
increased 3β-HSD expression [47].  
  Havelock et al. [48] found that follicle stimulating hormone (FSH) could stimulate the 
expression of nerve growth factor-induced clone B, which, in turn, up-regulates 3β-HSD type 2 in the 
human ovary.  
Studies have suggested that androgens can inhibit androgen production by the testes and that this 
repression can occur at the level of 3β-HSD regulation [49]. Rats treated with hCG displayed an 
increase in 3β-HSD activity, but R1881 (an androgen agonist) decreased hCG induction, whereas 
cyproterone acetate (an androgen antagonist) increased activity [50]. Similarly, dexamethasone   
(a glucocorticoid agonist) addition reduced both basal and cAMP stimulatory effects on 3β-HSD 
mRNA, but not cytochrome P450c17 activity in mouse Leydig cells [51]. 
The expression of 3β-HSD is altered by several different compounds, both of endogenous and 
exogenous origin. The presence of steroids and their regulating factors has been demonstrated to 
change the expression of 3β-HSD. In a study using porcine hepatocytes isolated from intact male pigs 
weighing 70 and 92 kg, different response patterns to steroid treatment depending on weight were 
discovered. In low-weight pigs, estrone sulfate produced no effect on 3β-HSD protein expression, 
whereas a significant induction was present in the hepatocytes from heavy-weight pigs [52]. Similarly, 
androstenone produced an increase in protein expression in heavy-weight pigs, whereas it had no effect 
on low-weight pigs. The suggested agonistic effect of steroids on 3β-HSD expression is not consistent 
with in vivo finding. In pigs, both surgical castration and injection with anti-gonadotropin-releasing Int. J. Mol. Sci. 2013, 14  17930 
 
 
hormone (immunocastration) have been demonstrated to increase the mRNA and protein expression of 
hepatic 3β-HSD [53]. Both castration methods lowered the circulating concentration of testosterone 
and androstenone.  
Compounds such as glucocorticoids and interleukins have also been demonstrated to regulate   
3β-HSD expression [54–56]. 
In summary, these findings indicate that the regulation of 3β-HSD is very complex, affected by 
several compounds and most likely different between tissues, different ages of organisms and species.  
5. 3β-HSD Isoforms in the Liver  
3β-HSD was purified from human liver by Takikawa et al. [57,58]. The adult mouse liver expresses 
3β-HSD types II, III, and IV, with type III predominating. Mouse type I expression ends at postnatal  
Day 20, whereas type V is detected at postnatal Day 40 and is male specific, and type II is expressed at 
low levels throughout development. These data suggest that the mouse liver enzyme might play a key 
role during foetal development [59]. Rat type III is expressed in the male rat liver and has a function in 
inactivating steroids in this tissue [60–62].  
Studies have also examined the regulation of 3β-HSD in the rodent liver. It appears that   
isoform-specific, sexually dimorphic regulation of 3β-HSD occurs in rats and mice [61,63].  
In the mouse and rat liver, sexually dimorphic GH expression regulates many drug-metabolizing 
and steroid-metabolizing enzymes [64–68]. GH expression in transgenic mice down-regulates the 
male-specific isoform of 3β-HSD [69]. These data suggest that circulating levels of steroids might 
affect the regulation of 3β-HSD activity in the liver, principally through altering GH and PRL levels, 
thereby resulting in steroid degradation feedback. This periodic variation in GH levels as a   
wave-formed transmitter-receiver signaling pattern is a general principle for gender differences and 
should be related to intracellular receiving “oscillators” with specific resonance characters [67,68]. 
Immunohistochemical studies localized 3β-HSD protein to the bile duct epithelium, and 3β-HSD 
activity has been mostly associated with the microsomal fraction (containing e.g., ER) [70,71]. Porcine 
hepatic 3β-HSD cDNA has been sequenced (GenBank accession number: NM_001004049). The gene 
has been mapped to the chromosome 4q16–4q21 [29]. The structure of the porcine 3β-HSD gene was 
described by Cue et al. [72]. The protein encoded by the porcine gene displays most similarity to 
human 3β-HSD type I (373 aa) and murine types I, II, II and IV. 
6. 3β-HSD in Testicular Leydig Cells 
The fluctuations in testicular steroid synthesis might be due to the changes in steroidogenic 
enzymes. As we have stated above, 3β-HSD is one of the key enzymes in the biosynthesis of 
androgens and almost all other biologically active steroids. Therefore, high 3β-HSD activity in the 
testes is essential for normal steroidogenesis and subsequently for reproduction.  
The majority of studies on the steroidogenic enzymes have used the Leydig cells of mice and rats as 
a model, whereas less information is available on the regulation of steroidogenic enzymes in porcine 
Leydig cells. In the Leydig cells of rats, mRNA for 3β-HSD is expressed at relatively high levels [32]. 
The expression of 3β-HSD during development is an indicator of testicular androgen production.   
Adult Leydig cells arise postnatally and encompass three developmental stages: progenitor, immature, Int. J. Mol. Sci. 2013, 14  17931 
 
 
and adult cells [73]. Rat testes at postnatal day 15 display 3β-HSD localization to the smooth   
ER of precursor Leydig cells and endothelial cells near 3β-HSD-positive Leydig cells [74,75].   
Pelletier et al. [76] have suggested that in the adult rat testes, 3β-HSD is restricted to the mitochondria. 
Clark et al. [77] studied Leydig cells from immature pigs and demonstrated that mRNA expression 
for 3β-HSD in porcine Leydig cells is lower than that for the CYP side-chain cleavage enzyme and 
CYP 17α-hydroxylase/C17-20-lyase. The same in vitro study revealed that treatment with hCG 
resulted in an increase in the mRNA for 3β-HSD in a dose- and time-dependent manner, indicating the 
regulation of 3β-HSD by gonadotropins as well as by some steroids.  
Other localization studies have examined 3β-HSD by immunocytochemistry in cynomolgus 
monkey testes, showing that 3β-HSD expression is observed in both Leydig and Sertoli cells [78]. 
Thus, the predominant site of 3β-HSD expression in the testes is in Leydig cells, but evidence exists 
for a parallel localization in Sertoli cells, at least in some primate species. 
The presence of 3β-HSD in pig testicular cytosol was first described by Nakajin et al. [79]. The 
expression of 3β-HSD in pig Leydig cells was localized to the theca interna and was unaffected by 
follicle atresia [80]. Therefore, the steroidal regulation of 3β-HSD in pig Leydig cells may act through 
a mechanism separate from the androgen receptor [77]. The expression of 3β-HSD, CYP450c17 and 
CYP450scc have been analyzed in several porcine fetal tissues, and the expression of 3β-HSD was 
found to be greater in fetal testes than in the fetal adrenal gland at all stages of development [81]. 
Studies have been performed to determine whether 3β-HSD regulation in fetal testes might be 
mediated through growth factors. Epidermal growth factor (EGF), transforming growth factor β  
(TGF-β), activin A, and GH have been shown to increase 3β-HSD activity. It has also been 
demonstrated that EGF treatment of porcine Leydig cells increases 3β-HSD activity [82]. 
Phospholipids may also play a role in the regulation of 3β-HSD activity as demonstrated in in vitro 
microsomal studies [83]. 
7. 3β-HSD in Other Tissues 
3β-HSD is expressed in a great number of tissue types in the body: adrenal, ovary, testis, placenta, 
liver, breast, prostate, skin, brain, kidney, cardiovascular, blood cells, and adipose [13]. Of special 
interest is the interplay between adrenals and gonads in steroid hormone metabolism [84]. 
The adrenals undergo a morphological differentiation from the fetal to the adult adrenal cortex. For 
non-primates, such as rats, guinea pigs and mice, there is no production of androgens in the adrenals 
due to the lack of cytochrome P450C17 [85]. Therefore, there are no detectable androgens in the serum 
in these animals when they are castrated. 3β-HSD is, however, expressed in the pig adrenals [81]. 
For the ovary, differential regulation of 3β-HSD plays an important role in the steroidogenic profile 
of ovarian tissue, and a complex interplay of pituitary and ovarian factors together maintains a tight 
control over the enzyme activities involved. Different species have different expression patterns during 
the development of the various tissues and during the oestrous cycles. The expression of 3β-HSD in 
pig ovaries was first described by Conley et al. [86] (for a review, see [87]). Similar to rats, 3β-HSD is 
localized to the theca interna layer of the pig follicle [88,89]. The pituitary control of steroidogenesis 
in the follicles is mainly mediated by FSH and LH, which causes an increase in cAMP and 
phosphatidylinositol turnover, resulting in an increase in the expression of 3β-HSD and other Int. J. Mol. Sci. 2013, 14  17932 
 
 
steroidogenic enzymes [90–92]. Other important factors for 3β-HSD expression in the ovaries are 
progesterone and androgen, and the connection between the receptors for these steroids and the 
expression of 3β-HSD has been found at some stages in the corpus luteum development [93–95]. 
Prostaglandin F2α and E2 have been observed to affect the accumulation of progesterone and 3β-HSD 
mRNA in porcine luteinised granulosa cells [96]. In the corpus luteum, the mitochondrial 3β-HSD is 
especially important for steroidogenesis because of the co-localization with P450scc [97]. mRNA for 
3β-HSD and other proteins has been measured in porcine follicles [88]. Increased expression 
throughout follicular development was observed. 
Adipose tissue plays an important role in the metabolism of sex steroids and has been shown to 
exhibit 3β-HSD activity [98]. One 3β-HSD isoform was characterized in porcine adipose tissue [29], 
which strongly implies that androstenone is metabolized in adipose tissue. The observed accumulation 
of androstenone in adipose tissue will then be dependent on the balance of supply and local turn-over. 
8. Dietary Influence on 3β-HSD 
A major gap in the current knowledge of the role of 3β-HSD is the extent to which nutrition 
interacts with genetics to inﬂuence 3β-HSD expression and activity and thus steroid levels. Some 
dietary components, such as spearmint (Mentha spicata), have been demonstrated to have an   
anti-androgenic effect on male rats, including depressed 3β-HSD activity [99]. Chen et al. [100] 
demonstrated that androstenone levels in fat slightly decreased after the consumption of raw potato 
starch for 2 weeks. Dietary components most likely accelerated androstenone hepatic metabolism and 
therefore reduced the concentrations in fat. In another study, chicory root affected both global 
androstenone levels in male pigs and the levels of 3β-HSD expressed in the liver [101]. 
Wang et al. [102] studied the effects of dietary soybean isoflavone on zearalenone residues in the 
muscle and liver of young female pigs and demonstrated that addition of zearalenone into the diet 
increased protein expression of 3α/3β-HSD. Interestingly, the addition of isoflavones to the 
zearalenone-contaminated diet decreased the hepatic protein expression of 3α/3β-HSD compared with 
the addition of zearalenone alone. Furthermore, the isoflavones daidzein, genistein, biochanin A and 
formononetin have been demonstrated to inhibit bovine adrenal 3β-HSD activity [103].  
Generally, dietary fats can influence the fatty acid composition of testicular lipids as well as the 
metabolism of testicular steroids and their concentrations in urine and plasma [104–106]. Testicular  
3β-HSD in rats has been demonstrated to be affected by dietary lipid composition [107]. 
Drugs can also influence 3β-HSD. For example, ciprofibrate fed to male rats dramatically decreases 
testicular 3β-HSD activity without changing either 3β-HSD protein or mRNA expression [108], which 
indicates a direct inhibition on enzyme activity level. 
9. The Boar Taint Phenomenon 
The sensory quality of meat originating from entire non-castrated male pigs may be negatively 
affected by the presence of high concentrations of skatole and/or androstenone. This phenomenon is 
known as boar taint [109]. The major factor determining the occurrence of boar taint in pig products is 
the balance between the biosynthesis and catabolism of androstenone and skatole [110]. Skatole is 
synthesized in the intestine of pigs and catabolized in the liver [110]. Androstenone is synthesized in Int. J. Mol. Sci. 2013, 14  17933 
 
 
the Leydig cells of the testes [111,112]. The production of androstenone is, like other sex steroids, 
mainly regulated by LH excreted by the pituitary gland. A portion of the androstenone is catabolized in 
the testes, whereas the rest is degraded in the liver. The catabolism of androstenone is conducted in 
two phases. Phase I is conducted by the enzymes 3α- and 3β-HSD with the production of 3α- and  
3β-androstenol, respectively [3]. These metabolites undergo Phase II sulpho-conjugation by 
hydroxysteroid sulphotransferases (isoform 2A1 and 2B1). Both testicular production and liver 
metabolism are important in the determination of the final concentrations of androstenone in fat. The 
enzymes responsible for the Phase I metabolism of skatole are to a great extent regulated by the 
presence of androstenone [113–119]. Cue et al. [72] detected a number of polymorphisms in the 
porcine 3β-HSD 5'-flanking region. However, none of these has been associated with variations in 
androstenone levels. This is in contrast to new results indicated that single nucleotide polymorphisms 
in the full-length gene have an impact on the accumulation of androstenone in Duroc pigs [120].  
At present, the regulation of porcine 3β-HSD in the testes is not fully elucidated. In principle, there 
are hypothetically two ways of connecting 3β-HSD to androstenone levels in male animals: Either 
inhibiting testis activity and thereby decreasing androstenone synthesis or increasing liver activity and 
thereby increasing androstenone degradation. There are indications that this second effect can be 
achieved via bioactive components in the feed, e.g., chicory root [101]. 
Interactions between 3β-HSD and anabolic steroids in relation to other physiological function in the 
animals should be established. Recent advances in biochemistry and molecular biology provide us with 
an excellent opportunity to increase our understanding of 3β-HSD regulations and the methods of its 
manipulation without side-effects. 
10. Conclusions 
3β-HSD is essential for both steroidogenesis and steroid degradation because of its dual 
functionality and depending on its localization in Leydig cells or hepatocytes. The molecular 
regulation of the human and rodent isoenzymes is complex and involves several factors and receptors, 
whereas the regulatory mechanisms of the porcine 3β-HSD are only starting to be elucidated.  
The expression and activity of 3β-HSD depend on the presence of several endogenous compounds, 
such as steroids, as well as exogenous toxic compounds, such as zearalenone. Moreover, dietary 
compounds have been demonstrated to affect the expression of 3β-HSD in various organs, including 
the liver. 
3β-HSD is a key enzyme in the metabolism of the boar taint compound androstenone in male pigs. 
Based on existing data, it is clear that the availability of androstenone depends on the balance between 
androstenone biosynthesis in the testes and the activities of 3β-HSD in the liver.  
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